Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.00
+0.39 (2.87%)
Nov 21, 2024, 4:00 PM EST - Market closed
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp.
| Country | United States |
| Founded | 1924 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,200 |
| CEO | Devdatt Kurdikar |
Contact Details
Address: 300 Kimball Drive, Suite 300 Parsippany, New Jersey 07054 United States | |
| Phone | 862 401 0000 |
| Website | embecta.com |
Stock Details
| Ticker Symbol | EMBC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001872789 |
| CUSIP Number | 29082K105 |
| ISIN Number | US29082K1051 |
| Employer ID | 87-1583942 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Devdatt Kurdikar | President, Chief Executive Officer and Director |
| Jacob P. Elguicze | Senior Vice President and Chief Financial Officer |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development and Corporate Secretary |
| Shaun Curtis | Senior Vice President of Global Manufacturing and Supply Chain |
| Colleen Riley | Senior Vice President and Chief Technology Officer |
| Pravesh Khandelwal | Vice President and Head of Investor Relations |
| Ginny Blocki | Senior Vice President of Global Marketing and Product Management |
| Jean M. Casner | Senior Vice President and Chief Human Resources Officer |
| Tom Blount | Senior Vice President and President of North America |
| Slobodan Radumilo | Senior Vice President and President of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 25, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Aug 12, 2024 | 8-K | Current Report |
| Aug 9, 2024 | 10-Q | Quarterly Report |
| Aug 9, 2024 | 8-K | Current Report |
| May 28, 2024 | SD | Form - SD |
| May 9, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 9, 2024 | 10-Q | Quarterly Report |
| May 9, 2024 | 8-K | Current Report |